Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Evidence-based medicine screened for likelihood of sentinel lymph node biopsy
April 14th, 2005
Scientists claimed that evidence-based medicine (EBM) helps screen for the need and validity of sentinel lymph node biopsy (SLNB) in breast cancer patients. According to recent research published in the journal American Surgeon, "SLNB has not been examined using the principles of EBM. Specifically, likelihood ratios have not been used to assess the validity of SLNB. The Surveillance, Epidemiology, and End Results (SEER) public database of the National Cancer Institute was used to establish the baseline or pretest probability of finding a positive lymph axillary node for each stage of breast cancer." "Rates of false negative results of SLNB for...
Source: Women's Health Weekly (2005-04-14)
|
